News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Celgene (CELG) (JOBS) Says Cancer Drug Revlimid Meets Trial Goal


1/13/2010 7:09:12 AM

Bookmark and Share

Reuters -- Celgene Corp (CELG.O) said on Tuesday that its cancer drug Revlimid met the main goal of a late-stage trial of patients with multiple myeloma who had undergone a stem cell transplant.

Read at Reuters

comments powered by Disqus
Reuters
Celgene
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES